NinePoint Medical Inc., a Cambridge medical device company specializing in optical imaging, said Thursday that it has completed a $34 million Series B financing led by Corning Inc.
Founding investors Third Rock Ventures and Prospect Venture Partners also participated in the round.
The company is in the midst of an ongoing launch of a device called the NvisionVLE Imaging System. The system is designed to help doctors visualize esophageal abnormalities.
NinePoint licensed the imaging technology for the system from Massachusetts General Hospital.
“With new hospitals adopting the technology every month, and with the support of our investors and strategic guidance of our board, we can continue to expand our sales force to facilitate the adoption of NvisionVLE at more centers,” Charles S. Carignan, MD, president and chief executive of NinePoint Medical, said in a statement.